Table 1. Patient Characteristics.
Item | Data |
---|---|
Age (years) | 71.6 ± 6.6 |
Sex (male/female) | 41/9 |
Etiology (B/C/NBNC/Al) | 10/31/4/5 |
Total bilirubin (mg/dL) | 0.91 ± 0.33 |
Prothrombin time (%) | 86.5 ± 10.2 |
Albumin (g/dL) | 3.83 ± 0.0.35 |
Platelets (× 104/µL) | 12.5 ± 5.6 |
Child-Pugh classification (A/B/C) | 45/3/0* |
Number of tumor nodules** | 4.5 ± 3.6 |
Max size of tumor (mm) | 31.3 ± 23.0 (10 - 135) |
Up-to-7 criteria (in/out) | 28/22 |
AFP (ng/mL) | 1,745.6 ± 11,253.1 (2 - 78,845) |
PIVKA-II (mAU/mL) | 2,331.4 ± 10,923.1 (0*** - 75,000) |
Values are expressed as mean ± SD. The range of numbers is shown in parenthesis. *Child-Pugh score was not assessed in two patients due to missing data. **Numbers of tumors ≥ 11 are expressed as 11. ***Values of PIVKA-II < 30 are expressed as 0. B: hepatitis B virus; C: hepatitis C virus; NBNC: non-B non-C; Al: alcohol; AFP: alfa-feto protein; PIVKA-II: protein induced by vitamin K absence or antagonist-II.